Related Experiment Video
Updated: May 2, 2026
10:32
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
56.9K
Sex differences in Parkinson's disease.
Glenda E Gillies1, Ilse S Pienaar1, Shiv Vohra1
1Division of Brain Sciences, Department of Medicine, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN, United Kingdom.
Frontiers in Neuroendocrinology
|March 11, 2014
Summary
Sex differences influence Parkinson's disease (PD) progression, with females showing neuroprotection. Understanding these brain dimorphisms could lead to hormone-based therapies for men and women.
Area of Science:
- Neuroscience
- Endocrinology
- Genetics
Background:
- Parkinson's disease (PD) affects men more frequently and at an earlier age.
- Current PD treatments focus on dopamine replacement, lacking disease-modifying agents.
- Females exhibit greater neuroprotection in early-stage PD compared to males.
Purpose of the Study:
- To explore how biological sex differences in the nigrostriatal dopamine (NSDA) system influence PD.
- To investigate the role of hormonal, genetic, and environmental factors in sex dimorphisms within the NSDA system.
- To identify potential therapeutic targets for delaying or halting PD progression based on sex-specific mechanisms.
Main Methods:
- Review of existing literature on sex differences in PD.
- Analysis of hormonal, genetic, and environmental influences on the NSDA system.
- Examination of neuroprotection mechanisms in female versus male subjects.
Main Results:
- Biological sex differences, influenced by hormones, genetics, and environment, largely determine sex disparities in PD.
- Significant neuroprotection is observed in females against early PD stages.
- Brain sex dimorphisms in the intact and injured NSDA system are key to understanding PD progression.
Conclusions:
- Understanding sex dimorphisms in the NSDA system is crucial for developing effective PD treatments.
- Sex-specific, hormone-based therapies show promise for optimizing treatment efficacy in both men and women.
- Targeting sex-specific mechanisms offers a potential avenue for disease-modifying interventions in Parkinson's disease.
Related Concept Videos
01:24Parkinson Disease l: Introduction
28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:24Parkinson's Disease: Treatment
1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
01:37Neural Regulation
34.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
34.8K
01:11Alterations in Muscle Tone lll
29
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
29